Saturday, June 12, 2021
Home Pharma

Pharma

Kite’s Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

SANTA MONICA, Calif.-- Kite, a Gilead Company (Nasdaq: GILD), announced today results from the primary analysis of ZUMA-3, a global, multicenter, single-arm, open-label Phase...

Cytovale Begins Enrollment in FDA 510(k) Clinical Validation Study of IntelliSep Rapid Sepsis Test

SAN FRANCISCO-- Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune-mediated diseases, today announced the...

Transgene and BioInvent Receive IND Approval from the U.S. FDA for BT-001, a Novel Oncolytic Virus for the Treatment of Solid Tumors

STRASBOURG, France & LUND, Sweden-- Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and...

Geneoscopy Announces Publication of Peer-Reviewed Article Highlighting Effective Noninvasive Screening Test for Colorectal Cancer Prevention

ST. LOUIS-- Geneoscopy Inc. today announced publication of the peer-reviewed article, “Multitarget Stool RNA Test for Noninvasive Detection of Colorectal Neoplasias in a Multicenter,...

Biogen and Ginkgo Bioworks Announce Collaboration Develop Novel Gene Therapy Manufacturing Platform

CAMBRIDGE, Mass. and BOSTON-- Biogen and Ginkgo Bioworks today announced a gene therapy collaboration. Together, the companies aim to redefine the industry standard for...

Libtayo® receives positive CHMP opinion for the treatment in Europe of two advanced cancers

Libtayo has been recommended for approval in the first-line treatment of certain patients with advanced non-small cell lung cancer whose tumors have ≥50% PD-L1...

Moderna and South Korea Explore Collaboration on mRNA Vaccines

CAMBRIDGE, Mass.-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Understanding (MoU) with...

PPD Opens Multipurpose Clinical Research Laboratory in Suzhou, China

SUZHOU, China-- PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, held a grand opening ceremony for its new multipurpose laboratory in Suzhou,...

BeiGene Announces Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy

CAMBRIDGE, Mass. & BEIJING-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY

NEW YORK & MAINZ, Germany-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC)...

Biomax Informatics : Universities use NeuroXM™ to study the connectome in drug-resistant epilepsy

PLANEGG, Germany-- Using Biomax Informatics' NeuroXM knowledge management platform, scientists from the Universities of Nottingham, Newcastle, Qingdao, Shanghai and Munich have studied the change...

Deerfield Management and Baylor College of Medicine Announce Blue Square Discoveries to Advance Novel Therapeutic Treatments

NEW YORK-- Deerfield Management Company (Deerfield), a healthcare investment management firm focused on advancing healthcare through investment, information and philanthropy, and Baylor College of...
- Advertisment -

Most Read